Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunophenotypic differences between uveal and cutaneous melanomas.

Satori Iwamoto1, Robert C Burrows, Robert E Kalina

  • 1Department of Medicine, Division of Dermatology, University of Washington Medical Center, Box 356524, Seattle, WA 98195-6524, USA. siwamoto@u.washington.edu

Archives of Ophthalmology (Chicago, Ill. : 1960)
|April 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastroenterologically relevant high alert medications prescribed to children with chronic diseases-a consensus-driven single-center pilot study.

Frontiers in pediatrics·2026
Same author

Evaluating Perceived Value of Pharmacogenomic Testing After a Personalized Therapeutics Clinic Consultation.

Clinical and translational science·2026
Same author

Complications of Therapeutic Plasma Exchange in Pediatric Neuroimmune Disorders.

Children (Basel, Switzerland)·2025
Same author

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI.

ESC heart failure·2025
Same author

Sharp increase in Chlamydia pneumoniae infections in 2024 in Germany.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

Results of the ACCOuNT Trial: A Multi-Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients.

Clinical pharmacology and therapeutics·2025
Same journal

The economics of the initial preventive physical examination in medicare-reply.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

Modification of silicone oil retention sutures in aphakic eyes with iris loss-reply;.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

December 2011 archives web quiz winner.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

About this journal.

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
Same journal

In memoriam: goodwin m. Breinin, MD (1918-2011).

Archives of ophthalmology (Chicago, Ill. : 1960)·2013
See all related articles

Immunophenotypic analysis reveals distinct differences between uveal and cutaneous melanomas. Uveal melanomas show strong labeling for MITF and other markers, unlike cutaneous melanomas, and cannot be subtyped by immunophenotype.

Area of Science:

  • Oncology
  • Dermatology
  • Ophthalmology

Background:

  • Melanomas are malignant neoplasms arising from melanocytes.
  • Cutaneous and uveal melanomas are distinct subtypes with differing prognoses and treatment strategies.
  • Immunophenotyping aids in classifying melanoma subtypes and understanding their molecular characteristics.

Purpose of the Study:

  • To delineate the immunophenotypic distinctions between uveal and cutaneous melanomas.
  • To evaluate the expression patterns of standard melanoma markers, p75 neurotrophin receptor (p75NTR), and microphthalmia transcription factor (MITF).

Main Methods:

  • Immunohistochemical analysis of 15 uveal melanomas (spindle, epithelioid, mixed subtypes) using antibodies for S100, tyrosinase, melan-A, HMB-45/HMB-50, MITF, and p75NTR.
  • Comparison of results with a prior study on cutaneous melanomas.

Related Experiment Videos

  • Tabulation of labeling intensity and pervasiveness.

    • Main Results:

    • S100 expression was weak and variable in uveal melanomas, contrasting with strong labeling in cutaneous melanomas.
    • p75NTR did not immunolabel uveal melanomas, unlike its role in differentiating cutaneous melanoma subtypes.
    • HMB-45, HMB-50, tyrosinase, melan-A, and MITF strongly labeled all uveal melanomas but not cutaneous melanomas.
    • Microphthalmia transcription factor (MITF) demonstrated particularly clear labeling in uveal melanomas.

    Conclusions:

    • Cutaneous and uveal melanomas share common molecular markers but exhibit significant immunophenotypic differences.
    • Differential expression of S100 protein is a key differentiator.
    • Uveal melanomas lack the immunophenotypic subtypes (spindle vs. epithelioid) observed in cutaneous melanomas.